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Aspergillosis of the central nervous system is a rare fungal infection that is mainly reported in patients with immune
deficiency, such as AIDS patients and organ transplant patients treated with immunosuppressive agents, and is
uncommon among patients with intact immune function. We report here a rare case of intracranial aspergillosis
in a patient who had previously undergone a parietal lobe tumorectomy. Aspergillus fumigatus was confirmed by
histopathology, and susceptibility tests reported that this infection should respond to voriconazole. We believe
the immunosuppression resulting from surgical trauma and glucocorticosteroid treatment may be contributing to
the infection, and therefore management of these two factors may improve the prognosis.
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Aspergillosis is an infection of tissues or cavities caused
by fungi of the genus Aspergillus [1]. Aspergillosis of
the central nervous system is a rare disease with a high
mortality that occurs more frequently in immunocom-
promised patients and is not often observed in immuno-
competent patients. The most common species to cause
aspergillosis of the CNS is Aspergillus fumigatus [2]. A.
fumigatus is found in the environment worldwide, but
only a few strains are pathogenic. Finding the source of
the infection is difficult, and the treatment of aspergillosis
is controversial. It may commonly present as meningitis,
fungal granuloma, mycotic aneurysm, or infarction. The
prognosis of the CNS aspergillosis, especially intracerebral
aspergillosis, is very poor, with a high mortality ranging
from 66% to 100% [3].
The case reported here is of an immunocompetent male
patient presenting with a simple Aspergillus intracranial
abscess 3 months after a craniotomy for a meningioma.
He underwent five procedures for the intracranial infec-
tion in conjunction with antifungal therapy and achieved* Correspondence: taojiang1964@163.com
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reproduction in any medium, provided the ora temporary remission. Unfortunately, the patient died
of recurrent infection 1.5 years after discharge from our
hospital.
Case presentation
A 42-year-old male patient underwent right parietal lobe
tumorectomy for a meningioma at Beijing Tiantan Hospital
in 2005 (Figure 1). He was discharged 8 days after the
surgery with a normal temperature and normal muscle
strength but an abnormal hemogram. Three months
later, he presented to a local hospital with pus at the
surgical incision site and was diagnosed with a surgical
site infection. One month later, he underwent a decom-
pressive craniotomy for increased intracranial pressure at
the local hospital. He was then transferred to our hospital
for better symptomatic management, pus evacuation and
treatment for occasional epilepsy. On admission, he was
oriented but had white exudates posterior to the incision
site. He could move his limbs, and his muscle strength
was normal. Computed tomography (CT) revealed en-
hancement of the dura with the surgical area surrounded
by cerebral edema.
Operation and treatment
The patient was treated with a third generation cephalo-
sporin for 10 days after the evacuation of the yellow-white. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 Images of the patient before the first procedure. Sagittal (A) and axial (B) contrast-enhanced MRI scan prior to the first admission
demonstrating an enhanced lesion located in the right parietal lobes with the enhanced meninges. (T1W).
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performed. Three weeks later, he experienced weakness
of his left extremities and hyperspasticity of his right
extremities. Routine blood tests showed an intermediate
cell percentage of 11.8%. CT and magnetic resonance
imaging (MRI) revealed an enhanced cavity wall with
an apparent brain tissue hydrocephalus.
Three months after the last surgery, the patient under-
went another procedure to treat the intracranial infection.
The thick abscess wall taken during the operation was
identified as an Aspergillus granuloma. After the surgery,
he was treated with an anti-epileptic and intravenous
administration of fluconazole for 1 week. Three weeks
later, a broken pustule was found on the incision site and
was treated with drainage and flushing with penicillin,
gentamicin, and cephalosporin.
After another 2 months, he developed walking dys-
function, along with a diminished muscle strength of 4/5
in his left upper limb and 3/5 in his left lower limb. MRI
demonstrated an irregular lesion on the apical lobe, and
there was massive hydrocephalus (Figure 2). He then
underwent his third and fourth operations for the intra-
cranial infection. The wound was drained and flushedFigure 2 Images of the patient after the second procedure due to int
T2-weighted image (B) prior to the third procedure of the infection demonstwith fluconazole and attenuated iodophors. The presence
of A. fumigatus was confirmed in the specimens and
secretions tested by the Skin & Fungus Lab of Peking
University First Hospital (Figure 3). Intravenous admin-
istration of voriconazole was started according to the
susceptibility test, with 400 mg bid on the first day and
200 mg bid from the second day on. Secretions from
the wound decreased.
Sixteen days later, a new open abscessed cavity was found
at the front of the wound. A cranial CT scan revealed obvi-
ous hydrocephalus that involved the motion area. He
underwent a procedure for the intracranial infection with
an expansion of the original incision site to resect the
hypodermis, the abnormal aponeurosis of the occipito-
frontalis muscle and the abnormal brain tissue. During
the postsurgical physical examination, his muscle strength
of the right limb was 4/5 compared with the 0/5 muscle
strength in his left limb. His body temperature was
elevated at 38.8°C, and a lumbar puncture was performed
that revealed leukocytosis in the collected sample of
yellow CSF. Intravenous voriconzole was started, resulting
in the cessation of pus secretion from the wound. However,
the patient started exhibiting some psychiatric symptoms,racranial infection. Sagittal contrast-enhanced MRI scan (A) and axial
rating an irregular lesion on the apical lobe with massive hydrocephalus.
Figure 3 Pathology of the specimens and secretions of the patient. Microscopic observation of the fungi demonstrating colonies of septate
(A) and acute angled, branched (B) fungal hyphae. (A) Silver staining × 400, (B) Silver staining × 200.
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2 weeks of oral voriconazole treatment. He was then
treated with intravenous itraconazole. One month later,
another CT demonstrated that there was no hydrops in
the hypodermis layer. He was discharged when he was
afebrile and had a normal tension on the operation area.
The muscle strength of his proximal left upper limb was
3/5. His distal left upper limb and left lower limb showed
a 0/5 muscle strength. His right upper and lower limbs
were 4/5.
This patient died from recurrent infection 1.5 years
later. The FBS of this patient was continuously normal
during the admission, indicating that the patient was not
diabetic. The WBC of this patient was normal and the
bacterial culture was negative during the admission.
Discussion
Aspergillosis of the CNS is associated with a high mortal-
ity and is extremely rare in immunocompetent patients
[3], especially after open surgery. There are only five
reports in the literature of the aspergillosis in the CNS
after craniotomy or tumorectomy in the last two decades
[2,4-7].
Previous reports indicated that the most common
sources of the CNS aspergillosis in immunocompetent
patients are the paranasal sinus, the lungs, and the
gastrointestinal tract. Intracranial infection occurs more
frequently by hematogenous routes and less frequently
by direct or contiguous spread [1,8]. A. fumigatus conidia
are abundant in the air and can be inhaled into the lungs
by anyone [9]. They can invade directly into the vessel wall
and spread to brain tissue by a hematogenous route from
the lungs [1]. In our case, no signs of lung infection were
found. His first tumorectomy was located in the right
parietal lobe, which was not associated with the base of
the skull or the paranasal area. Walsh et al. reported that
infection of the maxillary sinus might be complicated by
direct invasion into the palate with perforation into the
oral cavity or perforation of the nasal septum [10].
However, the infection in this patient was localized tothe site of the initial tumor. There was no evidence to
prove that A. fumigatus was disseminated from the
paranasals by direct or contiguous spread in this case.
Although this patient’s immune system was intact, he
was given an 8-day course of dexamethasone to treat his
hydrocephalus. Glucocorticosteroid decreases the chemo-
tactic and phagocytic function of lymphocytes, which play
an important role in immune surveillance. In addition,
there may be a state of impaired defense and increased
susceptibility to infection and septic complications during
the early postoperative period [11]. We believe that the
glucocorticosteroid treatment and the postoperative im-
mune suppression may be two potential risk factors for
Aspergillus infection of the CNS. Our patient had recur-
rent disease 1.5 years later. This recurrence suggests an
association between infection and reduced immunity.
Marinovic et al. reported a case of Aspergillus infection
following craniofacial trauma that involved the sinus, and
the source of the infection was thought to be the concrete
debris [8]. Kim et al. did not find the source of the post-
surgical Aspergillus infection in their case [5].
It took 3 months to confirm the diagnosis in our
patient due to a negative A. fumigatus culture. However,
the gold standard for diagnosis of aspergillosis is histo-
pathology. Although specific diagnosis might be possible
with some serological tests [5] and Masahiro Kami et al.
suggested that DWI and PCR of CSF could be useful in
the early diagnosis of CNS aspergillosis [12], the use of
these diagnostic techniques has not been fully developed.
Treatment of CNS aspergillosis solely with antifungal
agents has produced disappointing results [3]. The most
likely reason for the low effectiveness is the poor CNS
penetration of antifungal drugs [8], which leaves neuro-
surgical intervention combined with antifungal therapy as
the only acceptable option for treating CNS aspergillosis
[4,5,8]. Turgut had discussed a more effective therapy for
invasive fungal granuloma due to Aspergillus fumigatus in
an immunosuppressed patient [7]. A decompressive crani-
otomy and five procedures at the intracranial infection site
in conjunction with voriconazole and itraconazole therapy
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status to produce a temporary remission.
Voriconazole is the recommended therapy for CNS
aspergillosis, while itraconazole and posaconazole have
also been successful in treatment of CNS aspergillosis [10].
Prior to publication of Voriconazole recommendation,
amphotericin B had been the mainstay of therapy for
the past 25 years [1]. Marinovic and Siddiqui reported
high Amphotericin B effectiveness in their cases [3,8],
while Schwartz et al. concluded that treatment with
Amphotericin B and itraconazole was not effective [13].
In our case, the patient was treated by voriconazole for
23 days followed by itraconazole for 23 days, when the
infection was controlled.
Our patient died of recurrent infection 1.5 years later,
possibly due to a secondary Aspergillus infection that
occurred during the prolonged time it took to sort out
the original infection.
His relapse and death from the infection 1.5 years later
might be related to a progressive immunodeficiency due
to the glucocorticosteroid treatment and postoperative
immune suppression. We believe that better management
of these two factors might have improved the prognosis.
Conclusions
Aspergillus infection in the CNS is an extremely rare
disease. Although the source of the infection after the
aseptic craniectomy was not clear, immunosuppression
from surgical trauma and glucocorticosteroid treatment
may have contributed to the infection. Early diagnostic
confirmation of CNS Aspergillosis can improve the treat-
ment response and prognosis. Neurosurgical intervention
combined with voriconazole and itraconazole therapy is
useful in the treatment of patients with CNS Aspergillosis.
Susceptibility testing to confirm the optimal drugs com-
bined with neurosurgery therapy may improve the prog-
nosis of patients with CNS Aspergillosis.
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